Untreated Hearing Loss: The Single Biggest Modifiable Dementia Risk Factor

It's not a supplement, a diet, or a puzzle app. The single largest modifiable midlife risk factor for dementia is something far more ordinary — and far more fixable.

Why does hearing loss affect the brain at all?

Hearing loss isn't just an ear problem — it changes how hard the brain has to work, and how connected a person stays to the world around them.

Researchers point to three overlapping mechanisms. First, less auditory information reaches the brain, and areas that once processed sound may begin to atrophy or get repurposed, a pattern seen on brain scans showing faster volume loss in people with untreated hearing loss. Second, a brain straining to make out muffled speech is spending cognitive effort on decoding sound that would otherwise go toward memory and thinking — like running a background app that quietly drains the battery. Third, and perhaps most important for caregivers, hearing loss drives social withdrawal: conversations become exhausting, group settings become overwhelming, and people gradually opt out. Social isolation is itself an independent dementia risk factor, so hearing loss can compound risk through a second channel entirely.

How big is this risk, really?

The 2024 Lancet Commission on dementia prevention ranked hearing loss as the largest single modifiable risk factor identified across the entire life course.

The Lancet Commission's 2024 report lists 14 modifiable risk factors spanning early life through late life — including education, hearing, vision, blood pressure, smoking, and social isolation — and estimates that addressing all of them could prevent or delay around 45% of dementia cases worldwide. Among those 14, hearing loss in midlife carries the single largest estimated population impact of any individual factor, more than high blood pressure, more than smoking, more than any factor considered alone.

That doesn't mean hearing loss guarantees dementia, or that treating it guarantees prevention. It means that, across large populations, addressing hearing loss has more headroom to reduce dementia risk than most other single interventions researchers have studied.

Does treating hearing loss actually help?

The best direct evidence comes from a 2023 randomized trial: hearing aids slowed measurable cognitive decline in older adults already at elevated risk.

The ACHIEVE trial, published in The Lancet in 2023, followed 977 adults aged 70 to 84 with untreated hearing loss, randomly assigning them to a hearing intervention (hearing aids and audiologic counseling) or a health-education control. Across the full study population the effect was mixed, but among participants who already had more cardiovascular risk factors and were at higher baseline risk for cognitive decline, the hearing intervention slowed cognitive decline by 48% over three years compared to the control group.

That's a meaningful, randomized-trial-level result — a rarer thing in dementia prevention research, where most findings are observational. It doesn't mean every person who gets hearing aids will avoid dementia, but it's real evidence that treating hearing loss changes the trajectory for at least some higher-risk adults.

What this means for your family

A hearing test is one of the simplest, least invasive things you can do — and it's often skipped for years out of stigma or simple habit.

• If a loved one turns the TV up loud, asks people to repeat themselves, or has gone quieter in group conversations, consider a hearing test rather than assuming it's just "aging" or an early dementia sign.
• Hearing loss and early dementia can look similar from the outside — withdrawal, seeming not to follow conversation — so ruling hearing loss in or out is a useful diagnostic step either way.
• If hearing aids are recommended, expect an adjustment period; the brain needs time to relearn how to process amplified sound, and consistent daily use matters more than the specific device.
• Cost and stigma are the two biggest reasons people delay treatment — over-the-counter hearing aids (available without a prescription since 2022) have made the cost barrier significantly lower for mild to moderate loss.